PDS Biotechnology Corp (PDSB) insider trading
Every open-market stock purchase and sale by PDS Biotechnology Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Stephen C. Glover (Insider), $23K, 19 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent PDSB insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jan 12, 2026 | Kamil Ali-Jackson (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Frank Bedu-Addo (CEO) | Bought (not open market) | — |
| Jan 12, 2026 | Otis W Brawley (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Gregory Conn (C-suite exec) | Bought (not open market) | — |
| Jan 12, 2026 | Gregory Gene Freitag (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Ilian Iliev (Insider) | Bought (not open market) | — |
| Jan 12, 2026 | Spencer D. Brown (VP) | Bought (not open market) | — |
| Jan 12, 2026 | Lars Boesgaard (CFO) | Bought (not open market) | — |
| Jan 12, 2026 | Stephan Toutain (COO) | Bought (not open market) | — |
| Jan 12, 2026 | Kirk V. Shepard (C-suite exec) | Bought (not open market) | — |
| Jan 12, 2026 | Stephen C. Glover (Insider) | Bought (not open market) | — |
Who's trading PDSB
- Stephan Toutain, C-suite exec: other filings, last Jan 12, 2026
- Frank Bedu-Addo, CEO: other filings, last Jan 12, 2026
- Otis W Brawley, Insider: other filings, last Jan 12, 2026
- Lars Boesgaard, CFO: other filings, last Jan 12, 2026
- Spencer D. Brown, VP: other filings, last Jan 12, 2026
- Gregory Conn, C-suite exec: other filings, last Jan 12, 2026
- Gregory Gene Freitag, Insider: other filings, last Jan 12, 2026
- Stephen C. Glover, Insider: other filings, last Jan 12, 2026
- Ilian Iliev, Insider: other filings, last Jan 12, 2026
- Kamil Ali-Jackson, Insider: other filings, last Jan 12, 2026
- Kirk V. Shepard, C-suite exec: other filings, last Jan 12, 2026
Get free alerts when an insider at PDS Biotechnology Corp files a new trade →